Deutsch English Français

Contact

EP0004650

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0004650

EP0004650 - Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs [Right-click to bookmark this link]
Former [1986/05]	Cerebrally active drug and its application as well as its preparation
	[1986/05]
Status	Opposition rejected Status updated on 30.11.1990 Database last updated on 29.03.2025
Most recent event Tooltip	05.10.2005	Change: Appeal number
Applicant(s)	For all designated states BAYER AG 51368 Leverkusen / DE
	[N/P]
Inventor(s)	01 / Meyer, Horst, Dr. Theodor-HeuB-Strasse 110 D-5600 Wuppertal 1 / DE
	02 / Bossert, Friedrich, Dr. Claudiusweg 7 D-5600 Wuppertal 1 / DE
	03 / Kazda, Stanislav, Dr. Pahlkestrasse 55N D-5600 Wuppertal 1 / DE
	04 / Hoffmeister, Friedrich, Prof.Dr. Katernbergerstrasse 262 D-5600 Wuppertal 1 / DE
	05 / Vater, Wulf, Dr. Menchendahlerstrasse 23 D-5090 Leverkusen 3 / DE
	[N/P]
Application number, filing date	79100968.1	30.03.1979
Priority number, date	DE19782815578	11.04.1978 Original published format: DE 2815578
Filing language	DE
Procedural language	DE
Publication	Type:	A1 Application with search report
	No.:	EP0004650
	Date:	17.10.1979
	Language:	DE
	[N/P]
	Type:	B1 Patent specification
	No.:	EP0004650
	Date:	29.01.1986
	Language:	DE
	[1986/05]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	09.08.1979
Classification	IPC:	A61K31/445	[1986/05]
	CPC:	C07D211/90 (EP,US); A61K31/44 (EP,US); A61P25/28 (EP); A61P9/08 (EP)
Designated contracting states	BE, CH, DE, FR, GB, IT, LU, NL, SE
Title	German:	Verwendung von 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy-ethylester-5-isopropylester zur Herstellung von cerebralwirksamen Arzneimitteln	[1986/05]
	English:	Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs	[1986/05]
	French:	Usage de la 1,4-dihydro-2,6-diméthyl-4-(3-nitrophenyl)-3-beta-méthoxy ethylester-5-isopropylester-pyridine pour la préparation de médicaments ayant une activité cérébrale	[1986/05]
	Former [1986/05]	Cerebralwirksames Arzneimittel, und seine Verwendung sowie seine Herstellung
	Former [1986/05]	Cerebrally active drug and its application as well as its preparation
	Former [1986/05]	Médicament à action cérébrale et son application ainsi que sa préparation
Examination procedure	30.03.1979	Examination requested
	21.12.1979	Despatch of a communication from the examining division (Time limit: {0})
	28.03.1980	Fee for grant paid
	12.08.1980	Despatch of a communication from the examining division (Time limit: M04)
	01.12.1980	Reply to a communication from the examining division
	20.03.1981	Despatch of communication that the application is refused, reason: substantive examination {1}
	29.04.1985	Despatch of a communication from the examining division (Time limit: M02)
	06.05.1985	Reply to a communication from the examining division
	25.06.1985	Despatch of communication of intention to grant (Approval: )
	16.07.1985	Communication of intention to grant the patent
	10.08.1985	Fee for publishing/printing paid
Appeal following examination	20.05.1981	Appeal received No. T0297/88
	20.05.1981	Statement of grounds filed
	15.06.1982	Date of receipt of observations in an appeal [1982/25]
	02.08.1982	Invitation to file observations in an appeal (Time limit: M04) [1982/31]
Opposition(s)	Opponent(s)	01 01.10.1986 23.10.1986 ADMISSIBLE Bioinvest AB Karlavägen 119 S-115 26 Stockholm / SE
		02 22.10.1986 12.11.1986 ADMISSIBLE Hexal-Chemie GmbH Riedersteinstrasse 30 D-8180 Tegernsee / DE Opponents representative Beszédes, Stephan G. Patentanwalt Postfach 11 68 85201 Dachau / DE
		[N/P]
	Former [1986/51]
	Opponent(s)	01 01.10.1986 23.10.1986 ADMISSIBLE Bioinvest AB Karlavägen 119 S-115 26 Stockholm / SE
		02 22.10.1986 12.11.1986 ADMISSIBLE Hexal-Chemie GmbH Riedersteinstrasse 30 D-8180 Tegernsee / DE Opponents representative Beszédes, Stephan G., Dr. Patentanwalt Postfach 11 68 D-85201 Dachau / DE
	Former [1986/48]
	Opponent(s)	01 01.10.1986 23.10.1986 ADMISSIBLE Bioinvest AB Karlavägen 119 S-115 26 Stockholm / SE
	18.12.1986	Communication of observations of patent proprietor (Time limit: M02)
	18.12.1986	Invitation to proprietor to file observations on the notice of opposition
	18.12.1986	Reply of patent proprietor to notice(s) of opposition
	02.03.1987	Reply of parties involved to observations of patent proprietor
	06.05.1988	Date of despatch of rejection of opposition
	05.12.1989	Legal effect of rejection of opposition [1991/03]
Appeal following opposition	02.07.1988	Appeal received No. T0297/88
	05.09.1988	Statement of grounds filed
	05.12.1989	Result of appeal procedure: appeal of the opponent was rejected
Fees paid	Renewal fee
	13.03.1981	Renewal fee patent year 03
	15.03.1982	Renewal fee patent year 04
	24.02.1983	Renewal fee patent year 05
	17.02.1984	Renewal fee patent year 06
	25.02.1985	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[D]DE2302866 (YAMANOUCHI PHARMA CO LTD);
		[D]GB1358951 (BAYER AG);
		[D]DE2407115 (YAMANOUCHI PHARMA CO LTD)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 35p